Evidence map›Paper›PMID 39883726›Full record

ArticlePLoS pathogens2025

Extended receptor repertoire of an adenovirus associated with human obesity.

A Manuel Liaci, Naresh Chandra, Sharvani Munender Vodnala, Michael Strebl, Pravin Kumar, Vanessa Pfenning, Paul Bachmann, Rémi Caraballo, Wengang Chai, Emil Johansson and 5 more

Abstract read
In one paragraph

Article in PLoS pathogens, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

A Manuel LiaciInterfaculty Institute of Biochemistry, University of Tuebingen: Eberhard Karls Universitat Tubingen, Tuebingen, Germany.
Naresh ChandraDepartment of Clinical Microbiology, Umeå University, Umeå, Sweden.
Sharvani Munender VodnalaDepartment of Clinical Microbiology, Umeå University, Umeå, Sweden.
Michael StreblInterfaculty Institute of Biochemistry, University of Tuebingen: Eberhard Karls Universitat Tubingen, Tuebingen, Germany.
Pravin KumarDepartment of Clinical Microbiology, Umeå University, Umeå, Sweden.
Vanessa PfenningInterfaculty Institute of Biochemistry, University of Tuebingen: Eberhard Karls Universitat Tubingen, Tuebingen, Germany.
Paul BachmannInterfaculty Institute of Biochemistry, University of Tuebingen: Eberhard Karls Universitat Tubingen, Tuebingen, Germany.
Rémi CaraballoUmeå Centre for Microbial Research, Umeå University, Umeå, Sweden.
Wengang ChaiGlycosciences Laboratory, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, United Kingdom.
Emil JohanssonUmeå Centre for Microbial Research, Umeå University, Umeå, Sweden.
Mikael ElofssonUmeå Centre for Microbial Research, Umeå University, Umeå, Sweden.
Ten FeiziGlycosciences Laboratory, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, United Kingdom.
Yan LiuGlycosciences Laboratory, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, United Kingdom.
Thilo StehleInterfaculty Institute of Biochemistry, University of Tuebingen: Eberhard Karls Universitat Tubingen, Tuebingen, Germany.
Niklas ArnbergDepartment of Clinical Microbiology, Umeå University, Umeå, Sweden.ORCID 0000-0002-7069-6678

Funding

Wellcome Trust
6 · The paper itself

Abstract

Human adenovirus type 36 (HAdV-D36) has been putatively linked to obesity in animals and has been associated with obesity in humans in some but not all studies. Despite extensive epidemiological research there is limited information about its receptor profile. We investigated the receptor portfolio of HAdV-D36 using a combined structural biology and virology approach. The HAdV-D36 fiber knob domain (FK), which mediates the primary attachment of many HAdVs to host cells, has a significantly elongated DG loop that alters known binding interfaces for established adenovirus receptors such as the coxsackie- and adenovirus receptor (CAR) and CD46. Our data suggest that HAdV-D36 attaches to host cells using a versatile receptor pool comprising sialic acid-containing glycans and CAR. Sialic acids are recognized at the same binding site used by other HAdVs of species D such as HAdV-D37. Using glycan microarrays, we demonstrate that HAdV-D36 displays a binding preference for glycans containing a rare sialic acid variant, 4-O,5-N-diacetylneuraminic acid, over the more common 5-N-acetylneuraminic acid. To date, this sialic acid variant has not been detected in humans, although it can be synthesized by various animal species, including a range of domestic and livestock animals. Taken together, our results indicate that HAdV-D36 has evolved to recognize a specialized set of primary attachment receptors that are different from known HAdV types and coincides with a unique host range and pathogenicity profile.

Indexed as

Adenoviruses, HumanAdenovirus Infections, HumanCapsid ProteinsObesityReceptors, VirusAnimalsHumansPolysaccharidesVirus AttachmentCapsid ProteinsPolysaccharidesReceptors, Virus

Identifiers

PMID39883726
PMCPMC11813153

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.